A positive allosteric modulator of mGluR2
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CBiPES (hydrochloride)

Item No. 46423

Technical Information
Formal Name
N-(4′-cyano[1,1′-biphenyl]-3-yl)-N-(3-pyridiny lmethyl)-ethanesulfonamide, monohydrochloride
CAS Number
856702-40-4
Synonyms
  • LY566332
Molecular Formula
C21H19N3O2S • HCl
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥ 10 mg/ml
SMILES
O=S(N(CC1=CC=CN=C1)C2=CC=CC(C3=CC=C(C#N)C=C3)=C2)(CC)=O.Cl
InChi Code
InChI=1S/C21H19N3O2S.ClH/c1-2-27(25,26)24(16-18-5-4-12-23-15-18)21-7-3-6-20(13-21)19-10-8-17(14-22)9-11-19;/h3-13,15H,2,16H2,1H3;1H
InChi Key
QKUHSVQWWZBAKM-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    CBiPES is a positive allosteric modulator (PAM) of metabotropic glutamate receptor 2 (mGluR2).1 It selectively enhances glutamate-induced increases in intracellular calcium levels in mGluR2-expressing MCB3901 cells (EC50 = 92.8 nM) over those expressing other mGluR subtypes at 30 µM. CBiPES decreases stress-induced hyperthermia in a mouse model of anxiety and reduces spontaneous locomotor activity and PCP-induced hyperlocomotor activity in mice. It inhibits ketamine-induced histamine release in the medial prefrontal cortex in rats at 60 mg/kg.2 CBiPES (1 and 10 mg/kg) decreases L-DOPA- and benserazide-induced dyskinesia, psychosis-like behaviors, and parkinsonism in a marmoset model of MPTP-induced Parkinson’s disease.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Johnson, M.P., Barda, D., Britton, T.C., et al. Metabotropic glutamate 2 receptor potentiators: Receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). Psychopharmacology (Berl.) 179(1), 271-283 (2005).

    2. Fell, M.J., Katner, J.S., Johnson, B.G., et al. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge. Neuropharmacology 58(3), 632-639 (2010).

    3. Frouni, I., Kwan, C., Nuara, S.G., et al. Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset. J. Neural Transm. (Vienna) 128(1), 73-81 (2021).